News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mahboob Vaseem
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/26/2020 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 47,010 shares
@ $0
Paid exercise price by delivering 3,625 shares
@ $0.94, valued at
$3.4k
|
|
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 47,010 shares
@ $0
Paid exercise price by delivering 2,986 shares
@ $2.545, valued at
$7.6k
|
|
| 10/01/2019 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 13,702 options to buy
@ $135.6, valued at
$1.9M
Disposed/sold 11,594 options to buy
@ $75.3, valued at
$873k
Disposed/sold 10,999 options to buy
@ $48.2, valued at
$530.2k
Granted 10,959 options to buy
@ $4.71, valued at
$51.6k
|
|
| 08/06/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2019 |
4
| Mahboob Vaseem (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 8,083 shares
@ $0
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
4
| Mahboob Vaseem (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 8,083 shares
@ $0
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/03/2019 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Bought 15,128 shares
@ $6.61, valued at
$100k
Granted 12,500 shares
@ $0 |
|
| 01/02/2019 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 470,115 shares
@ $0
Granted 225,621 options to buy
@ $0.7445, valued at
$168k
|
|
| 08/20/2018 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Bought 30,000 shares
@ $2.43, valued at
$72.9k
|
|
| 03/15/2018 |
4
| Mahboob Vaseem (VP, Quality) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Disposed/sold 28,000 shares
@ $0 |
|
| 02/22/2018 |
4
| Mahboob Vaseem (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 24,000 options to buy
@ $9.8, valued at
$235.2k
Granted 6,000 restricted stock units
@ $0 |
|
| 02/22/2018 |
3
| Mahboob Vaseem (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
| 02/09/2018 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 33,201 shares
@ $0
Paid exercise price by delivering 4,632 shares
@ $4.05, valued at
$18.8k
|
|
| 11/08/2017 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 06/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2017 |
4
| Mahboob Vaseem (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 55,310 shares
@ $0
Paid exercise price by delivering 5,184 shares
@ $6.75, valued at
$35k
|
|
| 02/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|